Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (91-100 of 587) with videos related to

Pageof 59
Sort By:
Annals of the New York Academy of Sciences|November 17, 1994
Oxygen free radicals and neurodegeneration in Parkinson's disease: a role for nitric oxideM B Youdim, L Lavie, P Riederer
Neurotoxicity Research|January 2, 2007
Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorderC Mehler-Wex, P Riederer, M Gerlach
Neurology|December 1, 1996
Pharmacology of selegilineM Gerlach, M B Youdim, P Riederer
Pharmacopsychiatry|July 1, 1995
Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementiaW E Müller, E Mutschler, P Riederer
Clinical Neurology and Neurosurgery|January 1, 1979
Distinction between benign and malignant type of Parkinson's diseaseW Birkmayer, P Riederer, B H Youdim
Advances in Neurology|January 1, 1990
The role of MAO in dopaminergic transmissionP Riederer, C Konradi, M B Youdim
Biochemical Society Transactions|February 1, 1979
2-Phenylethylamine and amphetamine in human brain: effects of L-deprenyl in Parkinson's disease [proceedings]G P Reynolds, P Riederer, M Sandler
Advances in Neurology|January 1, 1996
Molecular mechanisms for neurodegeneration. Synergism between reactive oxygen species, calcium, and excitotoxic amino acidsM Gerlach, P Riederer, M B Youdim
European Journal of Pharmacology|June 5, 1992
The molecular pharmacology of L-deprenylM Gerlach, P Riederer, M B Youdim
Journal of Neural Transmission|January 1, 1987
HPLC analysis of somatostatin related peptides in putamen of Huntington's disease patientsG Sperk, G P Reynolds, P Riederer
Pageof 59

Showing results (91-100 of 587) with videos related to

Sort By:
Pageof 59
Annals of the New York Academy of Sciences|November 17, 1994
Oxygen free radicals and neurodegeneration in Parkinson's disease: a role for nitric oxideM B Youdim, L Lavie, P Riederer
Neurotoxicity Research|January 2, 2007
Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorderC Mehler-Wex, P Riederer, M Gerlach
Neurology|December 1, 1996
Pharmacology of selegilineM Gerlach, M B Youdim, P Riederer
Pharmacopsychiatry|July 1, 1995
Noncompetitive NMDA receptor antagonists with fast open-channel blocking kinetics and strong voltage-dependency as potential therapeutic agents for Alzheimer's dementiaW E Müller, E Mutschler, P Riederer
Clinical Neurology and Neurosurgery|January 1, 1979
Distinction between benign and malignant type of Parkinson's diseaseW Birkmayer, P Riederer, B H Youdim
Advances in Neurology|January 1, 1990
The role of MAO in dopaminergic transmissionP Riederer, C Konradi, M B Youdim
Biochemical Society Transactions|February 1, 1979
2-Phenylethylamine and amphetamine in human brain: effects of L-deprenyl in Parkinson's disease [proceedings]G P Reynolds, P Riederer, M Sandler
Advances in Neurology|January 1, 1996
Molecular mechanisms for neurodegeneration. Synergism between reactive oxygen species, calcium, and excitotoxic amino acidsM Gerlach, P Riederer, M B Youdim
European Journal of Pharmacology|June 5, 1992
The molecular pharmacology of L-deprenylM Gerlach, P Riederer, M B Youdim
Journal of Neural Transmission|January 1, 1987
HPLC analysis of somatostatin related peptides in putamen of Huntington's disease patientsG Sperk, G P Reynolds, P Riederer
Pageof 59